Fundraising Fox

Markwin Velders

Investor

Advisory Committee member at Curie Capital

Hilversum, North Holland, Netherlands

About

Advisory Committee member and seasoned biotech leader; holds a PhD.

Experience

  1. Prime Life Science BVManaging Director and Ownercurrent2020 — presentHilversum, Noord-Holland, Nederland
  2. Amarna Therapeutics B.V.Member of the Supervisory Boardcurrent2020 — presentLeiden, Zuid-Holland, Nederland
  3. Thuja CapitalAdvisory Board Membercurrent2021 — presentUtrecht, Nederland
  4. NECSTGENAdvisory Board Membercurrent2021 — presentLeiden, Zuid-Holland, Nederland
  5. ISA PharmaceuticalsMember Of The Supervisory Board2019 — 2024Leiden
  6. Oncode InstituteEntrepreneur In Residence2020 — 2023Utrecht, Nederland
  7. HollandBIOChairman Of The Board2017 — 2021
  8. HollandBIOBoard member2016 — 2021Den Haag en omgeving, Nederland
  9. Kite PharmaVP Operations2015 — 2020Amsterdam Area, Netherlands
  10. SomantiX BVChief Executive Officer2013 — 2015Utrecht Area, Netherlands
  11. T-Cell FactoryBusiness Development Consultant2013 — 2015Amsterdam Area, Netherlands
  12. Prime Life ScienceManaging Director and Owner2011 — 2015
  13. Institute QuantivisionManaging Director a.i.2012 — 2014Amsterdam Area, Netherlands
  14. TropIQDirector Business Development2012 — 2013Nijmegen Area, Netherlands
  15. TNOBusiness Unit Manager2009 — 2011
  16. TNOManager Operations TNO Biosciences2008 — 2011
  17. AM-PharmaVP R&D/CSO2005 — 2008
  18. CentocorQC consultant2004 — 2005
  19. Arrante BVManager application and product development2003 — 2004
  20. Glaucus ProteomicsDirector Immunology2002

Education

  1. Leiden UniversityPhD, Molecular Immunology1991 — 1996
  2. Leiden UniversityMaster of Science - MS, Biomedical Sciences1986 — 1991
  3. Weizmann Institute of ScienceZelig Eshhar lab/chimeric TCR/CAR-T, Molecular Immunology1990
  4. CLVMiddelbaar onderwijs1978 — 1986

Skills & more

Lifesciences39Biotechnology31R&D19Start-ups17Immunology15Molecular Biology12Vaccines8Entrepreneurship5Cell Culture7Science6Drug Discovery5Business Development4
+12 moreProtein ChemistryLife SciencesOncologyCancerGeneticsStrategyBiopharmaceuticalsInnovation ManagementValidationBusiness StrategyAssay DevelopmentGMP

Languages English

From Markwin's professional profile.

Colleagues at Curie Capital

Han de Groot
Partner at VOC Capital Partners B.V.
Helmuth van Es
Advisory Committee member at Curie Capital
Mariette van der Velden
Partner at Curie Capital
Minh Thu Nguyen
Fellow at Curie Capital
Mirjam Mol-Arts
Advisory Committee member at Curie Capital
Olivier Tak
Junior Partner at Curie Capital
Thom Frielink
Associate at Curie Capital

Frequently asked questions

Where does Markwin Velders work?
Markwin Velders is Advisory Committee member at Curie Capital.

Same school

Also attended Leiden University76

Andrea van ElsasInvestor at Third Rock VenturesJoost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at Syncona

+ 70 more

Also attended Weizmann Institute of Science19

Yaron DanielyGeneral Partner & Head of aMoon Alpha at aMoonReut ShemaPartner at aMoonHagai Marmor-KolletAssociate at aMoonItzik ParnafesVenture Partner at Key1 CapitalPete FlintInvestor at NFXShiran Tehila MashiahPrincipal at Peregrine Ventures

+ 13 more

Shared employers

Also worked at Oncode Institute4

Teri WilleyP2C Managing Director & Officer at Pathway to CuresRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesRudy DekeyserPartner, Head of Health Economic Funds at EQT Life SciencesJanine SchuurmanSenior Advisor at Bioqube Ventures

Also worked at TNO10

Erwin DassenVenture Partner at FrachtisMichael EngelmannPrincipal at imec.xpandMarcel LubbenPartner at Brightlands Venture PartnersBeau-Anne ChillaPartner at FORWARD.oneSjoerd NikkelenVenture Partner | Recommerce at DFF VenturesWard HeijBusiness Development Manager at Colesco Capital Collective

+ 4 more

Also worked at Centocor5

Deb TraversEntrepreneur-In-Residence at The Innovation SpaceGregory HarrimanPartner at BioAdvanceVenkat KokaInvestment Committee at PS27 VenturesMarian NakadaVice President at Johnson & Johnson Innovation – JJDCRamon BenetInvestor at Sky Ventures